Elicio Therapeutics, Inc. (ELTX) stock
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.06 (-3.85%)
Close on Nov 13, 2026Market cap $39.42MP/E –Yield –
Elicio Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Elicio Therapeutics's profit margin for the twelve months ending Mar 31, 2023 was -4468.1%. For fiscal 2022 it was -1225.9%, against -192.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -1225.9% | −1033.1 |
| FY2021 | Dec 31, 2021 | -192.8% | +2588.7 |
| FY2020 | Dec 31, 2020 | -2781.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | -1117.8% | +2043.7 |
| Q1 FY2022 | Mar 31, 2022 | -428.4% | +9460.3 |
| Q4 FY2021 | Dec 31, 2021 | 57.4% | +6348.2 |
| Q3 FY2021 | Sep 30, 2021 | -1075.6% | +1060.9 |
| Q2 FY2021 | Jun 30, 2021 | -3161.5% | −371.2 |
| Q1 FY2021 | Mar 31, 2021 | -9888.7% | −8360.1 |
| Q4 FY2020 | Dec 31, 2020 | -6290.8% | – |
| Q3 FY2020 | Sep 30, 2020 | -2136.5% | – |
| Q2 FY2020 | Jun 30, 2020 | -2790.3% | – |
| Q1 FY2020 | Mar 31, 2020 | -1528.6% | – |
See a number that looks wrong?